A Study to Determine Antibody Levels After Receiving COVID-19 Boosters of Any Kind

ModernaTX, Inc.1,501 enrolled

Overview

This study will investigate antibody levels with respect to time since receiving a COVID-19 booster shot. The study will be decentralized, where participants can complete all study tasks at home. Self-reported participant information will be collected via surveys conducted at intake and monthly throughout the study. Participants will also perform monthly at-home capillary blood draws via YourBio devices that will be mailed to the designated laboratory for sample processing and antibody testing.

Study Type

OBSERVATIONAL

Enrollment

1,501

Conditions

SARS-CoV-2

Eligibility

Sex: ALLMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Lives in the continental United States. * Has been vaccinated against COVID-19 with a U.S.-authorized vaccine (that is, received the single shot J\&J vaccine or both shots in the Pfizer or Moderna series). * Has received a COVID-19 booster between September 2021 and screening. * Is willing and able to submit vaccination card photo(s). * Is willing and able to self-collect capillary blood 3 times during the study period via an at-home whole-blood collection device (that is, the YourBio TAP II Device). Exclusion Criteria: * Has been diagnosed with significant cognitive impairment or dementia. * Has received more than one COVID-19 vaccine booster at screening. * Is currently participating in a COVID-19 vaccine clinical trial. * Is currently receiving chemotherapy or has received chemotherapy in the past 6 months. * Is currently taking steroids, such as prednisone, for any condition. * Has been diagnosed with or is taking medications for rheumatoid arthritis (RA), lupus or multiple sclerosis (MS). * Has received an organ transplant * Is currently undergoing dialysis of any kind (for example, hemodialysis or chronic ambulatory dialysis) for kidney disease.

Locations (1)

Evidation Health

San Mateo, California, United States

Outcomes

Primary Outcomes

Change in Antibody Levels Since Receiving a COVID-19 Booster Vaccine at 0, 1, and 2 Months Post Enrollment

Time frame: Baseline (Month 0), Month 1, and Month 2

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.